Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
Public ClinicalTrials.gov record NCT06267391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Sham-controlled Study for Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes (T2D) inadequately controlled on non-insulin glucose-lowering medications.
Study identification
- NCT ID
- NCT06267391
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2024
- Primary completion
- Jan 31, 2027
- Completion
- Sep 30, 2027
- Last update posted
- Aug 4, 2026
2024 – 2027
United States locations
- U.S. sites
- 37
- U.S. states
- 10
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35205 | — |
| Central Alabama Research | Birmingham | Alabama | 35209 | — |
| Velocity Clinical Research, Gardena | Gardena | California | 90247 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| UCLA | Los Angeles | California | 90065 | — |
| Hoag Memorial Hospital Presbyterian - Digestive Health Institute | Newport Beach | California | 92663 | — |
| Velocity Clinical Research, Hallandale Beach | Hallandale | Florida | 33009 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Universal Axon Clinical Research LLC | Miami | Florida | 33166 | — |
| University of Miami | Miami | Florida | 33166 | — |
| Quantum Clinical Research | Miami Beach | Florida | 33140 | — |
| West Orange Endocrinology | Ocoee | Florida | 34761 | — |
| Advent Health | Orlando | Florida | 32804 | — |
| Orlando Health | Orlando | Florida | 32806 | — |
| Health Synergy Clinical Research | West Palm Beach | Florida | 33407 | — |
| NorthShore University Health System | Evanston | Illinois | 60201 | — |
| Heartland Medical Research, Inc. | Clive | Iowa | 50325 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50266 | — |
| John Hopkins | Baltimore | Maryland | 21287 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Cooper Health System | Camden | New Jersey | 08103 | — |
| Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| The Ohio State University- Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Velocity Clinical Research - Austin | Austin | Texas | 78613 | — |
| Dell Medical School | Austin | Texas | 78712 | — |
| IMA Clinical Research - Austin | Austin | Texas | 78745 | — |
| The University of Texas Health Science Center at Houston | Bellaire | Texas | 77401 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
| Southwest Medical Center | Dallas | Texas | 75235 | — |
| University of Texas Southwestern Medical School - William P. Clements Jr. University Hospital | Dallas | Texas | 75235 | — |
| Epic Medical Research | DeSoto | Texas | 75115 | — |
| Houston Methodist Research Institute | Houston | Texas | 77030 | — |
| Juno Research, LLC | Houston | Texas | 77054 | — |
| Texas Diabetes & Endocrinology, P.A. | Round Rock | Texas | 78681 | — |
| Diabetes & Glandular Disease Clinic, P.A. | San Antonio | Texas | 78229 | — |
| IMA Clinical Research - San Antonio | San Antonio | Texas | 78229 | — |
| Mt. Olympus Medical Research | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06267391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06267391 live on ClinicalTrials.gov.